Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
Abstract
A compound of formula ** ** wherein X and Y are independently selected from the group consisting of N select, C = O, NR9, O, S, (CR6R7) n and C (= O) - (CR6R7) n; n is 1, 2 or 3; wherein when X is N, then Y is not N, provided that when X is N, then Y can still be NH; wherein when Y is N, then X is not N, provided that when Y is N, then X can still be NH; wherein when X is CH2, then Y is not CH2; wherein when X is NH, then Y is not NH; D is selected from the group consisting of N, CH and C; L is NH, O, C (O) NHC (O), OC (O) or a covalent bond; W is selected from the group consisting of Z1, Z2 and Z3 are independently selected from the group consisting of CR8 and N; R1 is selected from the group consisting of arylalkyl, heteroarylalkyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, heterocyclylalkyl, cycloalkylalkyl, alkenyl, alkynyl and substituted and unsubstituted alkyl; R2 is H; R3 is selected from the group consisting of alkyl, alkenyl, alkynyl, cycloalkyl, heteroaryl, heterocyclyl, heterocyclylalkyl, arylalkyl, heteroarylalkyl and cycloalkylalkyl substituted and unsubstituted, or R2 and R3 may be joined to form a ring containing at least two atoms N.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
22 members in 10 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 28284701 | United States of America | P |
Members22
| Document | Office | Kind | |
|---|---|---|---|
| WO02081443A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2002193595A1 | United States of America | A1 | |
| EP1385823A1 | European Patent Office (EPO) | A1 | |
| US2004024211A1 | United States of America | A1 | |
| US6716840B2 | United States of America | B2 | |
| JP2004535378A | Japan | A | |
| US2004248895A1 | United States of America | A1 | |
| EP1385823A4 | European Patent Office (EPO) | A4 | |
| US2005038027A1 | United States of America | A1 | |
| US6960582B2 | United States of America | B2 | |
| EP1385823B1 | European Patent Office (EPO) | B1 | |
| AT348097TThis record | Austria | T | |
| DE60216747D1 | Germany | D1 | |
| PT1385823E | Portugal | E | |
| US7189727B2 | United States of America | B2 | |
| DK1385823T3 | Denmark | T3 | |
| EP1767525A1 | European Patent Office (EPO) | A1 | |
| ES2278016T3 | Spain | T3 | |
| DE60216747T2 | Germany | T2 | |
| JP4172541B2 | Japan | B2 | |
| US7456183B2 | United States of America | B2 | |
| CY1107442T1 | Cyprus | T1 |
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP | |
| Change in the person of patent ownerEEIH | EEIH |
Numbers
- Application
- 2719463
Titles2
- German
- GUANIDINOVERBINDUNGEN ALS MELANOCORTIN-4-REZEPTOR (MC4-R) AGONISTEN
- English
- GUANIDINE COMPOUNDS AS MELANOCORTIN-4-RECEPTOR (MC4-R) AGONISTS
Classification
- CPC, 9
- C07D209/46
- A61P3/04
- C07D209/48
- A61P3/10
- C07D217/24
- A61P7/00
- C07D235/08
- A61P43/00
- C07D235/10
- IPC, 15
- A61K31 496
- A61K31 519
- A61K31 53
- A61P3 04
- A61P3 10
- A61P43 00
- A61P7 00
- C07D209 46
- C07D209 48
- C07D217 24
- C07D235 08
- C07D235 10
- C07D401 12
- C07D403 12
- C07D487 02